Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

The Blood-brain Barrier

The Blood-brain Barrier

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Neuroplasticity

Neuroplasticity

Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.

Glial Cells

Glial Cells

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Medical and surgical treatment of acute postoperative endophthalmitis].

Journal francais d'ophtalmologie·2024

Same author

[Tribute to Dr Mohammed Ezzouhairi].

Journal francais d'ophtalmologie·2024

Same author

[Ultra-widefield imaging of fundus albipunctatus discovered in a 30-year-old woman seen for night blindness].

Journal francais d'ophtalmologie·2023

Same author

[Management of ocular toxoplasmosis in France: Results of a modified Delphi study].

Journal francais d'ophtalmologie·2022

Same author

[Use of biotherapy in the management of Behçet's disease in a department of internal medicine].

La Revue de medecine interne·2019

Same author

Clinical spectrum of eye malformations in four patients with Mowat-Wilson syndrome.

American journal of medical genetics. Part A·2015

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

[Neuroprotection: is it close to us?].

¹Service d'ophtalmologie, Hôpital Général, CHU de Dijon, 3, rue du Faubourg-Raines, BP 1519, F-21033 Dijon cedex, France. Alain.Bron@CHU-Dijon.fr

Journal Francais D'Ophtalmologie

|June 12, 2009

Summary

Glaucoma is a progressive neurodegenerative disease involving retinal ganglion cell loss, not just high intraocular pressure (IOP). Research is exploring new therapies to slow glaucoma progression beyond IOP reduction.

Area of Science:

Ophthalmology
Neuroscience
Cell Biology

Context:

Glaucoma is increasingly recognized as a neurodegenerative condition, extending beyond its traditional definition as solely an intraocular pressure (IOP)-dependent disease.
The pathology involves progressive loss of retinal ganglion cells (RGCs) due to neuronal injury.
Apoptosis is a key mechanism implicated in RGC death within the glaucomatous process.

Purpose:

To explore the neurodegenerative aspects of glaucoma.
To understand the mechanisms of neuronal cell death, particularly apoptosis, in glaucoma.
To review emerging experimental models and therapeutic strategies for glaucoma management.

Summary:

Glaucoma is redefined as a neurodegenerative disease characterized by retinal ganglion cell death, driven by mechanisms like apoptosis.

More Related Videos

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

System for Focal, Closed-System Central Nervous System Injury

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Related Experiment Videos

Last Updated: Jun 22, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning

Strategies for Study of Neuroprotection from Cold-preconditioning

Published on: September 2, 2010

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

A Human Blood-Brain Interface Model to Study Barrier Crossings by Pathogens or Medicines and Their Interactions with the Brain

Published on: April 9, 2019

System for Focal, Closed-System Central Nervous System Injury

System for Focal, Closed-System Central Nervous System Injury

Published on: November 29, 2024

Current research focuses on understanding neuronal injury and developing novel therapeutic approaches.

These new therapies aim to complement existing IOP-lowering treatments by targeting disease progression.

Impact:

Shifts the paradigm of glaucoma understanding from purely IOP-centric to a neurodegenerative perspective.
Highlights the importance of targeting neuronal survival pathways in glaucoma treatment.
Promotes the development of add-on therapies to slow or stabilize glaucoma progression, improving patient outcomes.